Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.76
-0.48 (-5.83%)
Jan 30, 2026, 4:00 PM EST - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $7.53 million as of February 2, 2026. Its market cap has increased by 14.40% in one year.
Market Cap
7.53M
Enterprise Value
4.74M
1-Year Change
14.40%
Ranking
Category
Stock Price
$7.76
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $7.53M, a decrease of -97.68%. That is a compound annual growth rate of -18.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 7.53M | -7.82% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 8.25M |
| Alzamend Neuro | 8.17M |
| Immuron | 7.97M |
| MetaVia | 7.80M |
| Aptorum Group | 7.71M |
| VivoSim Labs | 7.62M |
| Calidi Biotherapeutics | 7.46M |
| Aptevo Therapeutics | 7.25M |